Genetic, molecular and physiological mechanisms involved in human obesity: Society for endocrinology medal lecture 2012

Clinical Endocrinology

Volumn 82, Issue 1, 2015, Pages 23-28

  Farooqi, Sadaf I ^a  

^a INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CELL PROTEIN; LEPTIN; MELANOCORTIN; MELANOCORTIN 2 RECEPTOR ACCESORY PROTEIN; MELANOCORTIN 4 RECEPTOR; TRANSCRIPTION FACTOR SIM1; UNCLASSIFIED DRUG;

ARTICLE; ENERGY BALANCE; ENERGY EXPENDITURE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETICS; HEALTH CARE PERSONNEL; HOMEOSTASIS; HUMAN; METABOLIC RATE; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; QUALITY OF LIFE; SIGNAL TRANSDUCTION; METABOLISM;

HUMANS; OBESITY;

EID: 84924277317     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12588     Document Type: Article

References (35)

1. Friedman, J.M. (2000) Obesity in the new millennium. Nature, 404, 632-634.
2. Sarlio-Lahteenkorva, S., Stunkard, A. & Rissanen, A. (1995) Psychosocial factors and quality of life in obesity. International Journal of Obesity and Related Metabolic Disorders, 19(Suppl 6), S1-S5.
3. Sorensen, T.I., Price, R.A., Stunkard, A.J., Schulsinger, F. et al. (1989) Genetics of obesity in adult adoptees and their biological siblings. BMJ, 298, 87-90.
4. Kennedy, G.C. (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proceedings of the Royal Society of London, 140, 578-596.
5. Zhang, Y., Proenca, R., Maffei, M. et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432.
6. Ahima, R.S., Prabakaran, D., Mantzoros, C. et al. (1996) Role of leptin in the neuroendocrine response to fasting. Nature, 382, 250-252.
7. Elmquist, J.K., Bjørbaek, C., Ahima, R.S. et al. (1998) Distributions of leptin receptor mRNA isoforms in the rat brain. The Journal of Comparative Neurology, 395, 535-547.
8. Huszar, D., Lynch, C.A., Fairchild-Huntress, V. et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell, 88, 131-141.
9. Montague, C.T., Farooqi, I.S., Whitehead, J.P. et al. (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature, 387, 903-908.
10. Farooqi, I.S., Jebb, S.A., Langmack, G. et al. (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England Journal of Medicine, 341, 879-884.
11. Clément, K., Vaisse, C., Lahlou, N. et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction [see comments]. Nature, 392, 398-401.
12. Farooqi, I.S., Wangensteen, T., Collins, S. et al. (2007) Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. New England Journal of Medicine, 356, 237-247.
13. Ozata, M., Ozdemir, I.C. & Licinio, J. (1999) Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. Journal of Clinical Endocrinology and Metabolism, 84, 3686-3695.
14. Quennell, J.H., Howell, C.S., Roa, J. et al. (2011) Leptin deficiency and diet-induced obesity reduce hypothalamic kisspeptin expression in mice. Endocrinology, 152, 1541-1550.
15. Farooqi, I.S., Matarese, G., Lord, G.M. et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. The Journal of Clinical Investigation, 110, 1093-1103.
16. Galgani, J.E., Greenway, F.L., Caglayan, S. et al. (2010) Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients. Journal of Clinical Endocrinology and Metabolism, 95, 851-855.
17. Hatoum, I.J., Stylopoulos, N., Vanhoose, A.M. et al. (2012) Melanocortin- 4 receptor signaling is required for weight loss after gastric bypass surgery. Journal of Clinical Endocrinology and Metabolism, 97, E1023-E1031.
18. Farooqi, I.S, Keogh, J.M., Yeo, G.S. et al. (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. New England Journal of Medicine, 348, 1085-1095.
19. Farooqi, I.S., Yeo, G.S., Keogh, J.M. et al. (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. The Journal of Clinical Investigation, 106, 271-279.
20. Greenfield, J.R., Miller, J.W., Keogh, J.M. et al. (2009) Modulation of blood pressure by central melanocortinergic pathways. New England Journal of Medicine, 360, 44-52.
21. René, P., Le Gouill, C., Pogozheva, I.D. et al. (2010) Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity. Journal of Pharmacology and Experimental Therapeutics, 335, 520-532.
22. Robertson, S.A., Koleva, R.I., Argetsinger, L.S. et al. (2009) Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling. Molecular and Cellular Biology, 29, 3367-3378.
23. Morris, D.L., Cho, K.W., Zhou, Y. et al. (2009) SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins. Diabetes, 58, 2039-2047.
24. Bochukova, E.G., Huang, N., Keogh, J., et al. (2010) Large, rare chromosomal deletions associated with severe early-onset obesity. Nature, 463, 666-670.
25. Doche, M.E., Bochukova, E.G., Su, H.W. et al. (2012) Human SH2B1 mutations are associated with maladaptive behaviors and obesity. The Journal of Clinical Investigation, 122, 4732-4736.
26. Gray, J., Yeo, G.S., Cox, J.J. et al. (2006) Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes, 55, 3366-3371.
27. Asai, M., Ramachandrappa, S., Joachim, M. et al. (2013) Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity. Science, 341, 275-278.
28. Yeo, G.S., Connie Hung, C.C., Rochford, J. et al. (2004) A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature Neuroscience, 7, 1187-1189.
29. Han, J.C., Liu, Q.R., Jones, M. et al. (2008) Brain-derived neurotrophic factor and obesity in the WAGR syndrome. New England Journal of Medicine, 359, 918-927.
30. Ramachandrappa, S., Raimondo, A., Cali, A.M. et al. (2013) Rare variants in single-minded 1 (SIM1) are associated with severe obesity. The Journal of Clinical Investigation, 123, 3042-3050.
31. Faivre, L., Cormier-Daire, V., Lapierre, J.M. et al. (2002) Deletion of the SIM1 gene (6q16.2) in a patient with a Prader-Willilike phenotype. Journal of Medical Genetics, 39, 594-596.
32. Goldstone, A.P. (2004) Prader-Willi syndrome: Advances in genetics, pathophysiology and treatment. Trends in Endocrinology and Metabolism, 15, 12-20.
33. Pearce, L.R., Atanassova, N., Banton, M.C. et al. (2013) KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. Cell, 155, 765-777.
34. Hardie, D.G., Ross, F.A. & Hawley, S.A. (2012) AMP-activated protein kinase: A target for drugs both ancient and modern. Chemistry & Biology, 19, 1222-1236.
35. He, M., Cornelis, M.C., Franks, P.W. et al. (2010) Obesity genotype score and cardiovascular risk in women with type 2 diabetes mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 327-332.